The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Share News (OXB)

Share Price Information for Oxford Biomedica (OXB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 220.00
Bid: 218.00
Ask: 219.50
Change: 1.50 (0.69%)
Spread: 1.50 (0.688%)
Open: 219.00
High: 223.00
Low: 212.50
Prev. Close: 218.50
OXB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET PRE-OPEN: Phoenix Group confirms talks for European sale

Tue, 18th May 2021 07:47

(Alliance News) - Stocks in London are set for a higher open on Tuesday following strength in Asia overnight, while the pound built on early gains after a better-than-expected UK jobs print.

The unemployment rate was 4.8% for the three months to March, easing from 4.9% in the three months to February. Consensus, according to FXStreet, had seen the March reading holding steady at 4.9%.

"The latest figures suggest that the jobs market has been broadly stable in recent months, with some early signs of recovery," the ONS said.

This coincides with the easing of lockdown restrictions in the UK. In March, schools in England reopened, followed by the lifting of shutters in April for outdoor hospitality, such as beer gardens, alongside non-essential retail and hairdressers.

The number of payroll employees increased for a fifth consecutive month in April, though does still remain 772,000 below pre-pandemic levels. The largest falls in jobs since February 2020 have been in the hospitality sector, among those aged under 25 years, and those living in London.

Sterling advanced further after the data, quoted at USD1.4183 early Tuesday compared to USD1.4119 at the London equities close on Monday.

Among London listings early Tuesday, Vodafone reported a slip in full-year earnings but held its dividend steady, Phoenix Group confirmed it is in talks to sell its European businesses, and Oxford Biomedica raised guidance on its AstraZeneca vaccine manufacturing deal.

IG says futures indicate the FTSE 100 index of large-caps to open 70.65 points higher, or up 1.0%, at 7,103.50 on Tuesday. The FTSE 100 closed down 10.76 points, or 0.2%, at 7,032.85 on Monday.

The higher start in Europe comes after a subdued session on Wall Street but a brighter mood in Asia overnight.

In the US on Monday, the Dow Jones Industrial Average ended down 0.2%, the S&P 500 down 0.3% and the Nasdaq Composite down 0.4%.

In Asia on Tuesday, however, the Japanese Nikkei 225 index ended up 2.1%. In China, the Shanghai Composite was up 0.1%, while the Hang Seng index in Hong Kong was up 1.3%. The S&P/ASX 200 in Sydney was up 0.6%.

"Asia's performance should set up Europe for a positive start later today. With the worst performers in Asia being the best ones by a country mile today, the lesson here is that an ocean of money still waits on the side-lines to buy equities on material pullbacks, Covid-19 be damned," said Jeffery Halley, a senior market analyst at Oanda.

In early UK company news, telecommunications firm Vodafone posted a "resilient" performance for its recently ended financial year.

Revenue for the financial year to March 31 was EUR43.81 billion, down 2.6% from EUR44.97 billion the year before. Pretax profit jumped to EUR4.40 billion, however, from just EUR795 million the year before, after financing costs fell to EUR1.03 billion from EUR3.55 billion.

Adjusted earnings before interest, tax, depreciation and amortisation fell 3.3% - or declining 1.2% on an organic basis - to EUR14.39 billion from EUR14.88 billion.

Vodafone kept its dividend for the year steady at 9.0 cents.

"I am pleased that we achieved full-year results in line with our guidance and we exited the year with accelerating service revenue growth across the business, with a particularly good performance in our largest market, Germany," said Chief Executive Nick Read.

For the year ahead, Vodafone expects adjusted Ebitda between EUR15.0 billion to EUR15.4 billion, and adjusted free cash flow of at least EUR5.2 billion.

Phoenix Group Holdings, noting press reports, confirmed it is in advanced talks over a potential sale of its European businesses.

"A sale of the European businesses will only be considered if it maximises value for shareholders. Discussions are on-going and there can be no certainty that any transaction will be agreed," the FTSE 100-listed long-term savings and retirement business said.

On Monday, Sky News reported that Phoenix is close to agreeing a GBP550 million deal to sell its European operations.

Oxford Biomedica raised its guidance after pharmaceutical firm AstraZeneca committed to an increase in the number of Covid-19 vaccines needed from the gene and cell therapy company in the second half of 2021.

The two signed an 18-month supply agreement in September under a three-year master supply and development agreement for the large-scale commercial manufacture of the Oxford-AstraZeneca vaccine.

As a result of Astra's commitment, Oxford Biomedica raised its revenue guidance for expected cumulative revenue from Astra by the end of 2021 to in excess of GBP100 million, from in excess of GBP50 million previously, and as such expects "significant growth" in operating Ebitda this year.

In economic data on Tuesday, Japan's economy contracted 1.3% in the three months to March after the government reimposed coronavirus restrictions in major cities as infections surged.

The quarter-on-quarter fall came after the world's third-largest economy grew for two quarters to December, but the expansion was stopped in its tracks by a winter increase in coronavirus cases.

The government imposed new virus states of emergency in January in response, urging people to stay at home and calling for restaurants to close earlier. The economic contraction was largely in line with economists' expectations.

The Japanese yen traded higher after the figures. Against the yen, the dollar slipped to JPY109.09 early Tuesday versus JPY109.20 late Monday.

The euro changed hands at USD1.2183, higher than USD1.2146.

Gold was quoted at USD1,869.76 an ounce early Tuesday, higher than USD1,865.60 on Monday. Brent oil was trading at USD69.68 a barrel, rising from USD69.24 late Monday.

In the economic calendar on Tuesday, besides UK jobs, there is eurozone employment and GDP at 1000 BST and US housing starts at 1330 BST.

Amazon.com is in discussions to acquire the MGM film studio for about USD9 billion, the Financial Times reported Tuesday, citing "people familiar with the matter". MGM's biggest shareholder is hedge fund Anchorage Capital, the newspaper noted. Anchorage started buying the studio's debt in 2010.

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
22 Apr 2024 14:45

UK earnings, trading statements calendar - next 7 days

Tuesday 23 April 
Alphawave IP Group PLCFull Year Results
Anglo American PLCTrading Statement
ASA International Group PLCFull Year Results
Associated British Foods PLCHalf Year Results
Eleco PLCFull Year Results
GB Group PLCTrading Statement
Jupiter Fund Management PLCTrading Statement
Property Franchise Group PLCFull Year Results
Taylor Wimpey PLCTrading Statement
tinyBuild IncFull Year Results
Trellus Health PLCFull Year Results
Wednesday 24 April 
1Spatial PLCFull Year Results
abrdn PLCTrading Statement
Ecora Resources PLCTrading Statement
Fresnillo PLCTrading Statement
Lloyds Banking Group PLCQ1 Results
Nichols PLCTrading Statement
PensionBee Group PLCFirst Quarter Results
PZ Cussons PLCTrading Statement
Quilter PLCQ1 Results
Reckitt Benckiser Group PLCTrading Statement
Sanderson Design Group PLCFull Year Results
Serica Energy PLCFull Year Results
Star Energy Group PLCFull Year Results
Tortilla Mexican Grill PLCFull Year Results
Tracsis PLCHalf Year Results
Warpaint London PLCFull Year Results
Thursday 25 April 
Aquila European Renewables PLCFull Year Results
Argo Blockchain PLCFull Year Results
AstraZeneca PLCQ1 Results
Barclays PLCQ1 Results
Checkit PLCFull Year Results
Coca-Cola Europacific Partners PLCTrading Statement
Destiny Pharma PLCFull Year Results
Dillistone Group PLCFull Year Results
Focusrite PLCHalf Year Results
Gem Diamonds LtdTrading Statement
Hikma Pharmaceuticals PLCTrading Statement
Hummingbird Resources PLCTrading Statement
Ibstock PLCTrading Statement
Inchcape PLCTrading Statement
J Sainsbury PLCFull Year Results
London Stock Exchange Group PLCQ1 Results
Persimmon PLCTrading Statement
Pinewood Technologies Group PLCFull Year Results
PPHE Hotel Group LtdTrading Statement
PureTech Health PLCFull Year Results
Relx PLCTrading Statement
Renewi PLCTrading Statement
Schroders PLCQ1 Results
Skillcast Group PLCFull Year Results
Travis Perkins PLCTrading Statement
Trifast PLCTrading Statement
Unilever PLCQ1 Results
WAG Payment Solutions PLCTrading Statement
Weir Group PLCTrading Statement
WH Smith PLCHalf Year Results
WPP PLCTrading Statement
Zinc Media Group PLCFull Year Results
Friday 26 April 
Facilities by ADF PLCFull Year Results
Kingspan Group PLCTrading Statement
NatWest Group PLC Q1 Results
Pearson PLCTrading Statement
Record PLCTrading Statement
Smurfit Kappa Group PLCTrading Statement
Taylor Maritime Investments LtdTrading Statement
Monday 29 April 
Beazley PLCTrading Statement
Biome Technologies PLCFull Year Results
Christie Group PLCFull Year Results
Gresham Technologies PLCFull Year Results
Jadestone Energy PLCFull Year Results
Oxford BioMedica PLCFull Year Results
SpaceandPeople PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
18 Apr 2024 09:43

LONDON BROKER RATINGS: HSBC likes Haleon, cuts Flutter to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
20 Mar 2024 16:18

EARNINGS AND TRADING: Roadside Real Estate trims Cambridge Sleep stake

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
5 Mar 2024 17:09

EARNINGS AND TRADING: Harland & Wolff wins major Falklands contract

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
5 Mar 2024 16:22

Oxford Biomedica shares rise on post-acquisition guidance

(Sharecast News) - Shares in cell and gene therapy specialist Oxford Biomedica were jumping on Tuesday afternoon, after the company updated the market on its medium-term financial guidance.

Read more
5 Mar 2024 08:57

LONDON BROKER RATINGS: Barclays cuts Bank of Ireland to 'equal weight'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
5 Feb 2024 11:34

EnSilica hires new chief financial officer from Oxford Biomedica

(Alliance News) - EnSilica PLC on Monday said it has appointed a new chief financial officer, who will join the company and board in May.

Read more
29 Jan 2024 12:35

IN BRIEF: Institut Merieux ups stake in Oxford BioMedica toward 10%

Oxford BioMedica PLC - Oxfordshire, England-based gene and cell therapy - Completes purchase of ABL Europe SAS from Institut Merieux SA, cementing the partnership between Oxford BioMedica and Institut Merieux. ABL is a cell and gene therapy contract development and manufacturing organization with facilities in Lyon and Strasbourg in France. For the EUR15 million acquisition, Oxford BioMedica will issue 3.1 million new shares to Lyon-based Institut Merieux at a price of 407.4 pence, well above its current market price. This is a 3.2% stake, and Institut Merieux already had 3.3%, giving it a total 6.5% holding. Oxford BioMedica says Institut Merieux intends to raise this to 10.0% by the end of the September.

Read more
7 Dec 2023 21:10

Oxford BioMedica posts optimistic outlook on uptick in contract value

(Alliance News) - Oxford BioMedica PLC on Thursday said it is on track to achieve its guidance for the year, amid an uptick in current contracted value and growth supported by new orders.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
4 Dec 2023 10:32

Oxford BioMedica buys ABL Europe for consideration of EUR15 million

(Alliance News) - Oxford BioMedica PLC on Monday said that it has entered a sale and purchase agreement with TSGH SAS for the acquisition of ABL Europe SAS.

Read more
20 Oct 2023 10:02

SMALL-CAP WINNERS & LOSERS: Record down as managed assets decline

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Friday.

Read more
18 Oct 2023 09:39

LONDON BROKER RATINGS: Citigroup cuts Wizz Air to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
27 Sep 2023 11:24

Director dealings: TUI, Oxford Biomedica board members linked to buys

(Sharecast News) - TUI was among those on the list of director buys on Wednesday after its chief executive officer purchased almost 50,000 shares.

Read more
22 Sep 2023 09:33

LONDON BROKER RATINGS: BoA likes Dowlais; JPMorgan cuts Phoenix Group

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.